Skip to content

Study IDs 47 Lipids Predicting Kidney Decline in Type 1 Diabetes

New biomarkers could revolutionize early detection of kidney disease in type 1 diabetes. Study finds distinct lipid profiles even when standard markers are normal.

In this image we can see there is a label with some text on the bottle which is on the table.
In this image we can see there is a label with some text on the bottle which is on the table.

Study IDs 47 Lipids Predicting Kidney Decline in Type 1 Diabetes

A groundbreaking study led by Farsad Afshinnia has identified 47 distinct lipids that could predict kidney function decline in type 1 diabetes patients. The research, published in the Journal of the American Society of Nephrology, sheds light on the differences between type 1 and type 2 diabetes in relation to kidney disease.

Historically, assessing kidney function involved estimated glomerular filtration rate and urine albumin excretion tests. However, these methods have limited predictive power in the early stages of diabetes when kidney function is normal. The study found that in type 1 diabetes patients, rapid kidney function decliners had significantly different lipid profiles compared to those with slow decline. The team identified elevated levels of ceramides and sphingomyelins as specific biomarkers in type 1 patients, unlike type 2 patients where increased diacylglycerols and triacylglycerols were more prominent.

The case-control study included over 800 type 1 diabetes patients, comparing those with rapid kidney function decline to those with minimal decline. Remarkably, these lipid predictors of diabetic kidney disease were evident even when standard markers were normal, suggesting a new platform for risk stratification and understanding the underlying mechanisms of progressive kidney disease.

The international research team's findings build upon earlier studies showing the impact of certain lipids on diabetic kidney disease progression in type 2 patients. These discoveries could revolutionize early detection and intervention strategies for kidney disease in diabetes, potentially saving thousands from kidney failure and related complications.

Read also:

Latest